Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of first routine immunization in preterm infants after hospital discharge
NL-OMON41573Active, not recruiting
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- Jan 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of DaKTP-Hib-HepB-Pneu vaccine in Preventable infectious diseases (VPD) (2 arms), sponsored by Noordwest Ziekenhuisgroep. Primary endpoints: Apnea events, Bradycardia events and 1 more. Started Jan 2015; status: active, not recruiting.
02
Drugs
DaKTP-Hib-HepB-Pneu vaccine
03
Conditions
Preventable infectious diseases (VPD)
Beyond the preview
Go deeper on NL-OMON41573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41573.